Horn, FriedemannFriedemannHornHackermüller, JörgJörgHackermüllerChrist-Breulmann, SabinaSabinaChrist-BreulmannReiche, KristinKristinReicheWirth, ManfredManfredWirthFröhner, MichaelMichaelFröhnerFüssel, SusanneSusanneFüssel2022-03-082022-03-082015https://publica.fraunhofer.de/handle/publica/310658WO15082420A1 [EN] The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.en610patent20130195377